Pharma & Medical ...
Follow
Find
18.9K views | +42 today
 
Scooped by Richard Meyer
onto Pharma & Medical Devices
Scoop.it!

FDA panel backs Novartis cystic fibrosis drug

FDA panel backs Novartis cystic fibrosis drug | Pharma & Medical Devices | Scoop.it

Drug advisers on Wednesday backed a novel form of Novartis AG's inhaled antibiotic that treats a lung infection linked to cystic fibrosis.A panel of outside advisers to the U.S.

more...
No comment yet.
Pharma & Medical Devices
Latest news on patients, healthcare and medical devices from around the Web
Curated by Richard Meyer
Your new post is loading...
Your new post is loading...
Scooped by Richard Meyer
Scoop.it!

Thoughts on the future of digital health - A view from the Center | Deloitte Center for Health Solutions Blog

Thoughts on the future of digital health - A view from the Center | Deloitte Center for Health Solutions Blog | Pharma & Medical Devices | Scoop.it
The potential of digital health to transform the health care industry is profound, but as yet, unrealized. In a recent Health Sciences Dbriefs webcast, we asked approximately 1,400 professionals for their views and opinions on the future of digital health.
more...
No comment yet.
Scooped by Richard Meyer
Scoop.it!

What You Should Know Before Watching Vice's Special About Curing Cancer

What You Should Know Before Watching Vice's Special About Curing Cancer | Pharma & Medical Devices | Scoop.it
Video Tomorrow night at 10 pm on the east and west coasts of the United States, Vice, the TV arm of the fast-growing Vice media empire, will air a special on HBO that posits that scientists are closing in on a cure for cancer. “Today in real time there is a revolution [...]
more...
No comment yet.
Scooped by Richard Meyer
Scoop.it!

MannKind's Afrezza Earns Lackluster Review from Independent Drug Arbiter

MannKind's Afrezza Earns Lackluster Review from Independent Drug Arbiter | Pharma & Medical Devices | Scoop.it
Adam Feuerstein's biotechnology blog, Biotech Beat, features Adam's opinion and analysis on an array of biotech and pharmaceutical stocks and companies.
more...
No comment yet.
Scooped by Richard Meyer
Scoop.it!

Bloomberg Intelligence reports 2015 will be strong year for biotech - Drug Store News

Bloomberg Intelligence reports 2015 will be strong year for biotech - Drug Store News | Pharma & Medical Devices | Scoop.it
Biosimilars and conditions like hepatitis C, NASH and oncology will all help contribute to growth within the biotech sector.
more...
No comment yet.
Scooped by Richard Meyer
Scoop.it!

GUEST BLOG: mHealth… the newest front-door to your Organization

GUEST BLOG: mHealth… the newest front-door to your Organization | Pharma & Medical Devices | Scoop.it
Healthcare Informatics Magazine | Health IT | Information Technology,Health care information technology & IT strategy news for CIOs, CMIOs & clinical informaticists. Learn about EMR EHR, ARRA HITECH, wireless technologies & meaningful use policy. Articles on patient safety, point-of-care tech & HIE analysis. Electronic medical records, health information exchange networks & hospital administration – financial – imaging news. Ambulatory care and business management info. Free Webinars and industry conferences.
more...
No comment yet.
Scooped by Richard Meyer
Scoop.it!

Sales of ADHD meds are booming. Here's Why.

Sales of ADHD meds are booming. Here's Why. | Pharma & Medical Devices | Scoop.it
Obamacare and new diagnostic criteria for adults could mean a major windfall for the makers of ADHD drugs.
more...
No comment yet.
Scooped by Richard Meyer
Scoop.it!

No. 1: Boston, MA - In Photos: Cities With The Longest Doctor Wait Times

No. 1: Boston, MA - In Photos: Cities With The Longest Doctor Wait Times | Pharma & Medical Devices | Scoop.it
Average wait time: 45.4 minutes
(Source: Merritt Hawkins)
more...
No comment yet.
Scooped by Richard Meyer
Scoop.it!

Why Big Pharma Must Cure Its Bad Rap

Why Big Pharma Must Cure Its Bad Rap | Pharma & Medical Devices | Scoop.it
VideoThe 2015 Harris corporate reputation poll is out and the news for Big Pharma isn’t good, to say the least.  In the poll—which measures the “reputation quotient” of the most visible American companies among the general public—Big Pharma ranked ninth out of 14 industries and was right in line with [...]
more...
No comment yet.
Scooped by Richard Meyer
Scoop.it!

Health Spending Is Rising More Sharply Again

Health Spending Is Rising More Sharply Again | Pharma & Medical Devices | Scoop.it
Drew Altman: Purely from a numbers perspective, growth in health prices does not seem to be the main reason for growth in health spending, which is trending back up as the economy improves and as more people get insured.
more...
No comment yet.
Scooped by Richard Meyer
Scoop.it!

Boehringer trims Connecticut workforce as sales suffer

Boehringer trims Connecticut workforce as sales suffer | Pharma & Medical Devices | Scoop.it
Struggling with falling sales, Boehringer Ingelheim is trimming its workforce in Connecticut, which accounts for about 2,700 staffers altogether.
more...
No comment yet.
Scooped by Richard Meyer
Scoop.it!

The FDA Still Has A Lot of Opportunities To Improve DTC Marketing | PM360

The FDA Still Has A Lot of Opportunities To Improve DTC Marketing | PM360 | Pharma & Medical Devices | Scoop.it
more...
No comment yet.
Scooped by Richard Meyer
Scoop.it!

Patient Demands for Cancer Tests and Treatments

Patient demands occur in 8.7% of patient-clinician encounters in the outpatient oncology setting. Clinicians deem most demands or requests as clinically appropriate. Clinically inappropriate demands occur in 1% of encounters, and clinicians comply with very few. At least in oncology, “demanding patients” seem infrequent and may not account for a significant proportion of costs.
more...
No comment yet.
Scooped by Richard Meyer
Scoop.it!

Biosimilars: Making the most of an “inexact” science - A view from the Center | Deloitte Center for Health Solutions Blog

Biosimilars: Making the most of an “inexact” science - A view from the Center | Deloitte Center for Health Solutions Blog | Pharma & Medical Devices | Scoop.it
There’s no question that biosimilars are a revolution in life sciences. As with most uncharted territory, however, generic and branded drugmakers should approach their entry into this new field strategically.
more...
No comment yet.
Scooped by Richard Meyer
Scoop.it!

Social Media Is A Lifeline For Patients With Rare Diseases

Social Media Is A Lifeline For Patients With Rare Diseases | Pharma & Medical Devices | Scoop.it
This weekend marked Rare Diseases Day 2015, a name that belies the pain and courage of patients who suffer from many of these illnesses. While each of these rare diseases is uncommon, occurring in less than 200,000 people in the U.S., together they affect about 1 in 10 people.⁠ Last year, [...]
more...
No comment yet.
Scooped by Richard Meyer
Scoop.it!

Google Enhances Health Information In Search Results

Google Enhances Health Information In Search Results | Pharma & Medical Devices | Scoop.it
On Feb. 10, Google announced that search results for health-related queries will receive enhanced information in the knowledge graph. This POV provides details about the update and its implications for pharmaceutical digital marketers.
more...
No comment yet.
Scooped by Richard Meyer
Scoop.it!

Exhibit of the Month: Improving Pharmaceutical Innovation

Exhibit of the Month: Improving Pharmaceutical Innovation | Pharma & Medical Devices | Scoop.it
Health Affairs is the leading peer-reviewed journal at the intersection of health, health care, and policy.
more...
No comment yet.
Scooped by Richard Meyer
Scoop.it!

Why The Pharma Industry Needs to Change

Why The Pharma Industry Needs to Change | Pharma & Medical Devices | Scoop.it
As someone with a chronic illness, I’ve often Tweeted about my many prescriptions, drugs and side effects. I’ve done as many thousands of others do online – I’ve discussed treatment plans, spoken with people on the other side of the … Continued
more...
No comment yet.
Scooped by Richard Meyer
Scoop.it!

Big Pharma Is America’s New Mafia

Big Pharma Is America’s New Mafia | Pharma & Medical Devices | Scoop.it
Pharmaceutical companies have more power than ever, and the American people are paying the price—too often with our lives.
more...
No comment yet.
Scooped by Richard Meyer
Scoop.it!

No, The New Cholesterol Drugs From Sanofi And Amgen Aren't Going To Cost $150 Billion A Year

No, The New Cholesterol Drugs From Sanofi And Amgen Aren't Going To Cost $150 Billion A Year | Pharma & Medical Devices | Scoop.it
In an article on the Health Affairs blog 4 CVS executives speculate that the new cholesterol lowering PCSK9 inhibitors from Amgen and Sanofi might achieve yearly sales of $150 billion or even higher. I think these numbers are a bit silly. But first let's take a look at their extremely bullish case: Simple Math... The CVS authors calculate that [...]
more...
No comment yet.
Scooped by Richard Meyer
Scoop.it!

John Oliver's Big Pharma Rant Is Amusing -- But Misleading

John Oliver's Big Pharma Rant Is Amusing -- But Misleading | Pharma & Medical Devices | Scoop.it
In his view, doctors are corrupt and their prescribing practices are governed by payments and perks from pharmaceutical companies. Do people think so little of doctors that they believe this?
more...
No comment yet.
Scooped by Richard Meyer
Scoop.it!

How Pfizer Is Using Big Data To Power Patient Care

How Pfizer Is Using Big Data To Power Patient Care | Pharma & Medical Devices | Scoop.it
Not so long ago, nearly every encounter with a doctor started with a receptionist waving a clipboard and asking me to take a seat. When I got into my doctor’s office, we‘d discuss the results from the blood test I’d taken the week before, my history and what I remembered [...]
more...
No comment yet.
Scooped by Richard Meyer
Scoop.it!

Data Snapshot: Dwarfed By Big Pharma, Biotech By The Numbers

Data Snapshot: Dwarfed By Big Pharma, Biotech By The Numbers | Pharma & Medical Devices | Scoop.it
Biotech fills the news these days – whether it's the announcement of exciting new clinical data, another high-flying IPO, or a big M&A deal. Amidst the significant “share of voice” in the coverage of young and emerging biotech in the media, it’s easy to forget the relative scale of the [...]
more...
No comment yet.
Scooped by Richard Meyer
Scoop.it!

US$67 billion worth of biosimilar patents expiring before 2020 / General / Biosimilars / Home - GaBI online - Generics and Biosimilars Initiative

US$67 billion worth of biosimilar patents expiring before 2020 / General / Biosimilars / Home - GaBI online - Generics and Biosimilars Initiative | Pharma & Medical Devices | Scoop.it
Generics and Biosimilars Initiative
more...
No comment yet.